Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs SynergenX Health

By GLP-1 ScorecardUpdated

CoreAge Rx
Site position #1

Higher grade

SynergenX Health
Site position #424

Lower grade

Score comparison

CoreAge Rx has the higher recorded score — 89.5/100 to 58.4/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

CoreAge Rx scores 89.5/100 (B+).

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueCoreAge Rx +46
92
46
Dose & formulationCoreAge Rx +36
88
52
Clinical oversightCoreAge Rx +27
93
66
Labs & monitoringCoreAge Rx +4
90
86
FulfillmentCoreAge Rx +40
95
55
Contract termsCoreAge Rx +20
67
47
CoreAge Rx · top barSynergenX Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricCoreAge RxSynergenX Health
WeighScore89.5/10058.4/100
GradeB+C
Site position#1#424
SemaglutideProduct page from $79/mo; navigation $99. Confirm selected quote.$150/mo (starting dose, plus a separate fee, compounded)
TirzepatideFrom $129/mo advertised; confirm selected charge, supply and renewal.Not disclosed
CoverageUS only; therapy-specific state restrictions apply10 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
CoreAge Rx

Site position #1 · B+

Strengths

  • Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
  • Advertises the same price across doses and no membership fee
  • Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy

What to consider

  • Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
  • FAQ no-rebill and payment-timing statements differ from the subscription and order policy
  • FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
  • Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
  • Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation
SynergenX Health

Site position #424 · C

Strengths

  • Compounded semaglutide from $150/mo including medication and refrigerated home shipping — no hidden fees stated on site
  • Backed by 64-clinic chain operating across 10 states with medical providers for in-person or telehealth care
  • Telehealth consultations from home; $100 initial visit, $40 follow-up every 1–3 months
  • Nutrition counseling and lifestyle planning included as part of personalized treatment program
  • Free weight-loss consultation option available before committing to paid evaluation

What to consider

  • Telehealth GLP-1 program currently Texas-only; rolling out more states but no timeline published
  • Tirzepatide not confirmed for online program; only compounded semaglutide explicitly listed
  • Labs not included or mentioned; no baseline bloodwork protocol disclosed on website
  • Dose-escalation pricing not published; $150/mo is entry dose only, higher doses may cost more
  • No LegitScript, named medical director, or publicly disclosed compounding pharmacy partner found

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard